SCHEMBL1121563

SCHEMBL1121563

COC(=O)c1cccc2oc(NC3CCNCC3)nc12

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.48
TOP2A P11388 2/20 0.47
HTR3A P46098 7/20 0.41
AURKA O14965 1/20 0.41
RPS6KB1 P23443 1/20 0.41
CDK1 P06493 1/20 0.41
CDK4 P11802 1/20 0.41
CCND1 P24385 1/20 0.41
CDK2 P24941 1/20 0.41
ROCK2 O75116 1/20 0.40
HCRTR1 O43613 3/20 0.39
HCRTR2 O43614 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
PARP1 P09874 1/20 0.38
HTR2C P28335 1/20 0.38
CYP2C19 P33261 1/20 0.37
KCNH2 Q12809 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1004928 0.88 RIPK1 (0.58) RIPK1TOP2AHTR3AROCK2HCRTR1
SCHEMBL4155160 0.87 RPS6KB1 (0.43) TOP2AHTR3AAURKARPS6KB1ROCK2
SCHEMBL1121610 0.85 RPS6KB1 (0.41) RIPK1TOP2AHTR3AAURKARPS6KB1
SCHEMBL1121676 0.84 HTR3A (0.42) HTR3AAURKARPS6KB1CDK1CDK4
SCHEMBL13543060 0.82 RPS6KA2 (0.44) RIPK1AURKARPS6KB1CDK1CDK4
SCHEMBL4308323 0.81 TOP2A (0.51) RIPK1TOP2AHTR3AHCRTR2KDM4E
SCHEMBL1121608 0.81 HTR3A (0.43) HTR3AAURKARPS6KB1PARP1CYP2C19
SCHEMBL1121524 0.79 ALDH1A1 (0.49) CDK2KDM4EALDH1A1PARP1
SCHEMBL1005701 0.78 TOP2A (0.56) RIPK1TOP2AHTR3AKDM4EALDH1A1
SCHEMBL1121260 0.77 POLB (0.43) HTR3ACDK2KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101253171-B Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives HOFFMANN LA ROCHE 2011-06-15 CN disclosed
EP-1924579-B1 BENZOOXAZOLE, OXAZOLOPYRIDINE, BENZOTHIAZOLE AND THIAZOLOPYRIDINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2011-02-09 EP disclosed
US-20090163517-A1 BENZOOXAZOLE, OXAZOLOPYRIDINE, BENZOTHIAZOLE AND THIAZOLOPYRIDINE DERIVATIVES BINGGELI ALFRED 2009-06-25 US disclosed
CN-101253171-A Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives HOFFMANN LA ROCHE (CH) 2008-08-27 CN disclosed
EP-1924579-A2 BENZOOXAZOLE, OXAZOLOPYRIDINE, BENZOTHIAZOLE AND THIAZOLOPYRIDINE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2008-05-28 EP disclosed
US-20070093521-A1 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives F. HOFFMANN-LA ROCHE AG (CH) 2007-04-26 US disclosed
WO-2007025897-A2 BENZOOXAZOLE, OXAZOLOPYRIDINE, BENZOTHIAZOLE AND THIAZOLOPYRIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163517-A1 BENZOOXAZOLE, OXAZOLOPYRIDINE, BENZOTHIAZOLE AND THIAZOLOPYRIDINE DERIVATIVES SSTR5, NPY5R, NPY1R RIPK1 4172/4885TOP2A 1550/4885HTR3A 465/4885
US-20070093521-A1 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives SSTR5, NPY5R, NPY1R RIPK1 4172/4885TOP2A 1550/4885HTR3A 465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.